Search Studies

Testing a New Treatment for Myeloproliferative Disorders

The purpose of this study is to see how well the study drug, INCA033989, works for treating myeloproliferative disorders. We want to find what effects, if any, this therapy may have on people. We also want to find out what is the highest dose that can be given without causing severe side effects.

Study Topics

Cancer Cancer: Myeloma

Testing the Study Drug Navtemadlin for Patients with Myelofibrosis

This study aims to find out more about using the drug navtemadlin with ruxolitinib. We want to see if these drugs together are safe and helpful for treating myelofibrosis. We also want to know if navtemadlin can help patients who don't improve with just ruxolitinib.

Study Topics

Cancer Cancer: Myeloma